Topiramate Tablet, Film Coated
Product Images NDC 72789-004

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72789-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789004 Label (72789004)

This is a description of a pharmaceutical product from VeLow PD-Rx Pharmaceuticals. It contains Topiramate USP, a medication for the treatment of seizures and migraines. The package has 21 tablets with 100 mg of Topiramate USP. It includes instructions on dosage and storage, as well as a warning to keep the medication out of reach of children. The lot number is A21036. It also includes a phone number for medical advice and reporting side effects. The rest of the text appears to be misinterpreted or not useful.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-1jpg (Figure 1)

This text provides a graph showing the cumulative rates for time to first seizure for patients taking Topiramate 50 mg/day and Topiramate 400 mg/day. The graph includes a legend indicating which line represents which dose. The graph shows a statistically significant difference between the two doses with a p-value of .0002. The X-axis displays time in days and the Y-axis displays cumulative seizure rate with values ranging from 0.00 to 0.50.*

FDA Label Image

Figure-2 (Figure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.